Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.
Science. 2014 May 9;344(6184):641-5. doi: 10.1126/science.1251102.
Science. 2014.
PMID: 24812403
Free PMC article.